Pittsburgh Pirates fans are excited to know if their star pitcher, Paul Skenes, will pitch tonight against the San Diego Padres. With no injuries reported, hopes are high for the young star. Here is the latest update on Skenes’ injury status and the game’s importance.
Paul Skenes is expected to start against the Padres tonight
The Pittsburgh Pirates play the San Diego Padres tonight at 5:10 p.m. ET at PNC Park. Paul Skenes, the 22-year-old star, is likely to pitch, with no injury problems reported. He’s been amazing this season, with a 2.15 ERA and 77 strikeouts. His fast pitches, reaching 98 mph, make him a fan favourite. The Pirates, with a 21-36 record, need Skenes to help them win. Manager Don Kelly says Skenes has been great, like his 6.2 scoreless innings against the Diamondbacks. The game will be on SDPA and SportsNet PT. Fans are eager to see Skenes take on the Padres.Also Read: Shohei Ohtani shatters 73-year-old Dodgers record as Yankees watch history unfold
Pirates aim to snap losing streak
The Pirates are looking to end their losing streak against the Padres. The Pirates haven’t beaten the Padres since 2023. The Pirates sit at a measly .184 batting average, which further strains the Pirates’ pitching staff. The biggest key to tonight’s game is Skenes, who is sitting out of this game, and makes this game even harder to win. The Padres, led by Jackson Merrill, have a strong lineup, challenging the Pirates’ hopes. General manager Ben Cherington has dismissed trade rumors about Skenes, emphasizing his role in the team’s future. Fans at Petco Park are ready to support Pittsburgh, hoping for a win to boost morale. Skenes’ recent dominance, like his scoreless outing against the Diamondbacks, shows what he brings to the team. The Pirates’ young core, including Oneil Cruz, needs to step up to support their pitchers. This game is a chance to show progress and end the skid. A victory could set a positive tone for the series and help the Pirates climb out of their early-season slump, giving fans hope for a better 2025.